Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial cell membranes and surface proteins are fundamental structures that maintain the viability and virulence of pathogens. The bacterial cytoplasmic membrane and the outer membrane of Gram-negative bacteria serve as critical barriers and sites for energy transduction and nutrient transport (Silhavy et al., 2010, Cold Spring Harbor Perspectives in Biology). These membranes contain unique components not found in human cells, such as lipopolysaccharides (LPS) in bacteria and ergosterol in fungi, which provide a basis for selective toxicity (Li et al., 2006, Clinical Infectious Diseases). Drugs like polymyxins and daptomycin target these membranes to cause rapid depolarization and cell death, while surface proteins like adhesins are targeted to prevent host tissue colonization (Foster et al., 2014, Nature Reviews Microbiology). Despite their clinical utility, targeting these structures can be associated with significant side effects, such as nephrotoxicity, and is increasingly complicated by the emergence of sophisticated resistance mechanisms (Brogden, 2005, Nature Reviews Microbiology).
Antimicrobials targeting these structures typically act through physical disruption of the lipid bilayer (e.g., polymyxins binding to LPS), pore formation leading to cytoplasmic leakage (e.g., daptomycin or amphotericin B), or by blocking surface proteins involved in adhesion and host cell entry (Papo & Shai, 2005, Biochemistry; Epand & Vogel, 1999, Biochimica et Biophysica Acta).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell membranes and surface proteins.